
Research peptides
TB-500
Also known as Thymosin beta-4 fragment
TB-500 is a trade name rather than a standardized scientific term. Analytical studies of TB-500 products identified an N-acetylated fragment of thymosin beta-4 (residues 17–23, Ac-LKKTETQ), though the name is also used loosely for thymosin beta-4 itself.
- Container
- Glass vial, crimp seal, flip-top cap
- Storage
- -20 °C, desiccated
- Paperwork
- Lot certificate (HPLC + mass spec) shown before you pay
Lot certificates
You’ll see American Peptides on the lab’s copy. They’re our supplier.
- 10 mg, lot TB10-0803: 99.68% purity (RP-HPLC), 10.23 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7595
Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.
What researchers study it for
- Anti-doping detection and metabolism
- Cell migration and wound-healing assays
- Actin-binding region of thymosin beta-4
- Rat tendon-repair model (single study)
How it is thought to work
Thymosin beta-4 is a 43-amino-acid actin-sequestering protein; its LKKTETQ region is the central actin-binding site and has been associated with cell migration and angiogenesis in laboratory studies. Whether the acetylated fragment reproduces these effects is not well established, and a 2024 study noted that TB-500's own biological effects had not been documented.
Where the research stands
Preclinical research. Fragment-specific research is limited to laboratory, animal and anti-doping studies, and WADA prohibits thymosin-β4 and derivatives such as TB-500 (S2).
Sources
- Esposito S, et al. (2012). Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Testing and Analysis.
- Ho EN, et al. (2012). Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma by liquid chromatography-mass spectrometry. Journal of Chromatography A.
- Sosne G, et al. (2010). Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB Journal.
- Rahaman KA, et al. (2024). Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro. Journal of Chromatography B.
Read more
For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.
